Metabolexis focuses on GLP-1 weight loss and type 2 diabetic drug discoveries to improve accessibility and meet unprecedented demand.
LED BY CLARKE CAPITAL, THE NEW FUNDING ROUND WILL ACCELERATE THE COMPANY’S DRUG DISCOVERY PIPELINE
Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit
Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer Test, BRACAnalysis CDx® and/or MyChoice® CDx cancer tests
PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient.
Revolutionizing Data Collection in Cardiology with Proprietary Wireless Ecosystem
Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis
The company expects to receive U.S. approval late next year.
Company Ranks Top 2 in Healthcare Equipment and Services Industry
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions